glp-1 obesity drug updates today New oral delivers up to 12% weight loss in 36 weeks Upcoming wave of hormone-based therapies
Description
Neuropharmacology (2014) 84:3145
Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis
Incretin-based therapy for diabetes: what a cardiologist needs to know
Slley E, Kun S, Szijrt IA, Kertsz M, Wittmann I, Molnr GA
Natural products and GLP-1 modulation 6.1
Whether it's the fitness industry, food industry, shopping, where we spend our money, disease reduction and so forth
